The Vice President of the Republic, Raquel Peña, announced that the governing body has agreed with the pharmaceutical companies Pfizer and BioNTech that 7.9 million doses of the BNT162b2 vaccine will be issued against the Covid-19.
The agreement was made in representation of the Dominican Republic and the Minister of Public Health, Dr. Plutarco Arias.
Raquel Peña indicates that this agreement between Pfizer and BioNTech and the Dominican governor “we are working on to ensure that the Dominican people have access to the security manner, as President Abinader promised from his speech.
The agreed dose will be summed up in the country in the transition of 2021, starting from the second quarter of this year, one of the vacancies BNT162b2 will receive the transit permit by the General Directorate of Medicinal Products, Food and Sanitary Products (Digits) acquisition approved by the National Congress.
Following the final results of the clinical trial, a large scale was announced by Pfizer and BioNTech, the vacancy reported in the joint has a 95% increase in Covid-19 prevention.
About ambient temperatures
Depending on the pharmaceutical, the type of vaccine and the techniques employed for its development, the dose of vaccines against Covid-19 should be maintained at temperatures that oscillate between -80 degrees Celsius and 8 degrees Celsius; specifically the vacancy developed by Pfizer and BioNTech requires temperatures between -80 and -70 degrees Celsius for conservation.
Currently, the Essentials and Central Medical Assistance Program (Promise / Cal) has also identified ultracongelians’ propositions for BNT162b2 vacancy, with a capacity to cover up to 400 miles; while following fast-moving and ongoing conversations with other possible aliens to increase their ability to raise up to 1 million doses.